Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

898 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. D'Haens G, et al. Among authors: scholmerich j. Gastroenterology. 2007 Feb;132(2):763-86. doi: 10.1053/j.gastro.2006.12.038. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258735 Review. No abstract available.
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.
Campieri M, Gilat T, Hanauer S, Korelitz B, Lauritsen K, Malchow H, Martin F, Miglioli M, Modigliani R, Present D, Schölmerich J, Sutherland L. Campieri M, et al. Among authors: scholmerich j. Inflamm Bowel Dis. 1996 Winter;2(4):265-7. doi: 10.1097/00054725-199612000-00007. Inflamm Bowel Dis. 1996. PMID: 23282593 No abstract available.
Evidence-based medicine: applied science?
Schölmerich J, Hanauer SB. Schölmerich J, et al. Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):177. doi: 10.1038/ncpgasthep0468. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16582938 No abstract available.
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators. Schreiber S, et al. Among authors: scholmerich j. Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16. Am J Gastroenterol. 2010. PMID: 20234346 Clinical Trial.
Standards for trials of therapy in inflammatory bowel disease.
Sutherland LR, Hanauer S, Scholmerich J; Task Force on Clinical Trials of the International Organisation for the Study of Inflammatory Bowel Disease. Sutherland LR, et al. Among authors: scholmerich j. Inflamm Bowel Dis. 1997 Winter;3(4):277-83. Inflamm Bowel Dis. 1997. PMID: 23282874 No abstract available.
Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.
Pariente B, Mary JY, Danese S, Chowers Y, De Cruz P, D'Haens G, Loftus EV Jr, Louis E, Panés J, Schölmerich J, Schreiber S, Vecchi M, Branche J, Bruining D, Fiorino G, Herzog M, Kamm MA, Klein A, Lewin M, Meunier P, Ordas I, Strauch U, Tontini GE, Zagdanski AM, Bonifacio C, Rimola J, Nachury M, Leroy C, Sandborn W, Colombel JF, Cosnes J. Pariente B, et al. Among authors: scholmerich j. Gastroenterology. 2015 Jan;148(1):52-63.e3. doi: 10.1053/j.gastro.2014.09.015. Epub 2014 Sep 21. Gastroenterology. 2015. PMID: 25241327
898 results